STOCK TITAN

Apyx Medical Corporation to Release Fourth Quarter and Fiscal Year 2021 Financial Results on March 17, 2022

Rhea-AI Impact
(Neutral)
Rhea-AI Sentiment
(Neutral)
Tags
Rhea-AI Summary

Apyx Medical Corporation (NASDAQ:APYX) is set to release its financial results for the fourth quarter and fiscal year 2021 on March 17th, before the market opening. A conference call will be held at 8:00 a.m. ET on the same day, allowing stakeholders to discuss the results and participate in a Q&A session. The call can be accessed via phone or a live webcast on the Company's website. A replay will be available until March 31, 2022.

Apyx Medical specializes in innovative medical devices, showcasing its Helium Plasma Technology.

Positive
  • None.
Negative
  • None.

CLEARWATER, Fla.--(BUSINESS WIRE)-- Apyx Medical Corporation (NASDAQ:APYX) (the “Company”), a maker of medical devices and supplies and the developer of Helium Plasma Technology, marketed and sold as Renuvion® in the cosmetic surgery market and J-Plasma® in the hospital surgical market, today announced that financial results for the fourth quarter and fiscal year 2021 will be released before the market opens on Thursday, March 17th.

Management will host a conference call at 8:00 a.m. Eastern Time on March 17th to discuss the results of the quarter and fiscal year, and to host a question and answer session. To listen to the call by phone, interested parties may dial 877-407-8289 (or 201-689-8341 for international callers) and provide access code 13726730. Participants should ask for the Apyx Medical Corporation Call. A live webcast of the call will be accessible via the Investor Relations section of the Company’s website and at:

https://themediaframe.com/mediaframe/webcast.html?webcastid=rZxrcAMy.

A telephonic replay will be available approximately two hours after the end of the call through March 31, 2022. The replay can be accessed by dialing 877-660-6853 for U.S. callers or 201-612-7415 for international callers and using the replay access code: 13726730. The webcast will be archived on the Investor Relations section of the Company’s website.

About Apyx Medical Corporation:

Apyx Medical Corporation is an advanced energy technology company with a passion for elevating people’s lives through innovative products in the cosmetic and surgical markets. Known for its innovative Helium Plasma Technology, Apyx is solely focused on bringing transformative solutions to the physicians and patients it serves. The Company’s Helium Plasma Technology is marketed and sold as Renuvion in the cosmetic surgery market and J-Plasma in the hospital surgical market. Renuvion offers surgeons and physicians a unique ability to provide controlled heat to the tissue to achieve their desired results. The J-Plasma system allows surgeons to operate with a high level of precision and virtually eliminating unintended tissue trauma. The Company also leverages its deep expertise and decades of experience in unique waveforms through original equipment manufacturing (OEM) agreements with other medical device manufacturers. For further information about the Company and its products, please refer to the Apyx Medical Corporation website at www.ApyxMedical.com.

Investor Relations:

ICR Westwicke on behalf of Apyx Medical Corporation

Mike Piccinino, CFA

investor.relations@apyxmedical.com

Source: Apyx Medical Corporation

FAQ

When will Apyx Medical release its fourth-quarter financial results?

Apyx Medical will release its fourth-quarter financial results on March 17th, before the market opens.

What time is the conference call for Apyx Medical's financial results?

The conference call will be held at 8:00 a.m. Eastern Time on March 17th.

How can I access the Apyx Medical conference call?

You can access the Apyx Medical conference call by dialing 877-407-8289 for U.S. callers or 201-689-8341 for international callers, using access code 13726730.

Is there a replay available for the Apyx Medical conference call?

Yes, a telephonic replay will be available until March 31, 2022.

What is Helium Plasma Technology by Apyx Medical?

Helium Plasma Technology is Apyx Medical’s innovative approach marketed as Renuvion in cosmetic surgery and J-Plasma in hospital settings.

Apyx Medical Corporation

NASDAQ:APYX

APYX Rankings

APYX Latest News

APYX Stock Data

57.97M
35.04M
16.18%
40.43%
0.68%
Medical Devices
Surgical & Medical Instruments & Apparatus
Link
United States of America
CLEARWATER